153
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis

, , , , &
Pages 883-892 | Published online: 11 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

George J Wan, John Niewoehner & Kyle Hayes. (2023) Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence. ClinicoEconomics and Outcomes Research 15, pages 499-512.
Read now

Articles from other publishers (2)

George Iliopoulos & Dimitrios Daoussis. (2023) FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?. Central Asian Journal of Medical Hypotheses and Ethics 3:4, pages 220-231.
Crossref
. (2021) Repository corticotropin injections appear to be cost effective for MS in the USA. PharmacoEconomics & Outcomes News 890:1, pages 24-24.
Crossref